\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationHYbrid
Demystifying artificial intelligence to harness innovation for humans is at the core of Europe’s digital transition. During this event, meet innovations, entrepreneurs and ventures driving the future of artificial intelligence.
This event is part of the INNOVEIT WEEKS event series. More information on the event website
This event is organised by EIT Manufacturing, an Innovation Community within the European Institute of Innovation & Technology (EIT) that connects the leading manufacturing actors in Europe
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI Continent Deployment: Best use of technologies
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
